Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2017-06-27
2021-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Resistance Training and Protein Supplementation in Healthy Elderly Men and Women.
NCT01004588
A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01110369
Combined Nutrient Intake and Muscle Protein Synthesis
NCT01239277
Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01109628
Protein Supply in Elderly
NCT01317511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young healthy subjects
20-30 years old, max 1h of exercise per week
No interventions assigned to this group
Elderly with a normal physical function
65-80 years old, max 1h of exercise per week
No interventions assigned to this group
Elderly with a decreased physical function
65-80 years old, max 1h of exercise per week, SPPB under 9 or frailty score lower then 10
No interventions assigned to this group
Active elderly
65-80 years old, minimal 3h of exercise per week
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject should be in sufficient health to participate in the experimentations, to be judged by the responsible MD based on the subject's medical history
* Caucasian origin (see study groups)
Exclusion Criteria
Aneurysm clips Implanted neural stimulator Implanted cardiac pacemaker of defibrillator Cochlear implant Iron- containing corpora aliena in the eye or brain Artificial (heart) valves which is contraindicated for MRS Claustrophobia
* Diagnosed with diabetes mellitus
* Poor health as judged by the responsible medical doctor
* Heart problems: In case of an abnormal ECG in rest, this will be discussed with both the participant and the responsible medical doctor
65 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Netherlands Organisation for Scientific Research
OTHER_GOV
Top Institute Food and Nutrition
OTHER
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Schrauwen, Prof . dr.
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mevenkamp J, Bruls YMH, Mancilla R, Grevendonk L, Wildberger JE, Brouwers K, Hesselink MKC, Schrauwen P, Hoeks J, Houtkooper RH, Buitinga M, de Graaf RA, Lindeboom L, Schrauwen-Hinderling VB. Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T. Nat Commun. 2024 Oct 24;15(1):9159. doi: 10.1038/s41467-024-53292-4.
Mancilla R, Pava-Mejia D, van Polanen N, de Wit V, Bergman M, Grevendonk L, Jorgensen J, Kornips E, Hoeks J, Hesselink MKC, Schrauwen-Hinderling VB. Invasive and noninvasive markers of human skeletal muscle mitochondrial function. Physiol Rep. 2023 Jun;11(12):e15734. doi: 10.14814/phy2.15734.
Mancilla RF, Lindeboom L, Grevendonk L, Hoeks J, Koves TR, Muoio DM, Schrauwen P, Schrauwen-Hinderling V, Hesselink MK. Skeletal muscle mitochondrial inertia is associated with carnitine acetyltransferase activity and physical function in humans. JCI Insight. 2023 Jan 10;8(1):e163855. doi: 10.1172/jci.insight.163855.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mitohealth
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.